カテゴリー： QYResearch, 世界, 医療/バイオ

世界の皮下埋め込み型除細動器市場インサイト及び予測（心室性頻拍、肥大型心筋症、心室異形成、その他）

◆英語タイトル：Global Subcutaneous Implantable Cardioverter Defibrillator Market Insights, Forecast to 2028

QYResearchが発行した調査報告書（QY22JLX10138）◆商品コード：QY22JLX10138
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2022年7月（※2025年版があります。お問い合わせください。）
◆ページ数：97
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、皮下埋め込み型除細動器のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に皮下埋め込み型除細動器の世界市場のxxx％を占める「心室性頻拍」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
皮下埋め込み型除細動器の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの皮下埋め込み型除細動器市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

皮下埋め込み型除細動器のグローバル主要企業には、Abbott、Koninklijke Philips、Nihon Kohden Corporation、Medtronic、Boston Scientific、MicroPort Scientific、ClearPoint Neuro、BIOTRONIK SE、ZOLL Medicalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

皮下埋め込み型除細動器市場は、種類と用途によって区分されます。世界の皮下埋め込み型除細動器市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
心室性頻拍、肥大型心筋症、心室異形成、その他

【用途別セグメント】
病院、専門診療所、外来手術センター、在宅医療

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 皮下埋め込み型除細動器製品概要
- 種類別市場（心室性頻拍、肥大型心筋症、心室異形成、その他）
- 用途別市場（病院、専門診療所、外来手術センター、在宅医療）
- 調査の目的
・エグゼクティブサマリー
- 世界の皮下埋め込み型除細動器販売量予測2017-2028
- 世界の皮下埋め込み型除細動器売上予測2017-2028
- 皮下埋め込み型除細動器の地域別販売量
- 皮下埋め込み型除細動器の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別皮下埋め込み型除細動器販売量
- 主要メーカー別皮下埋め込み型除細動器売上
- 主要メーカー別皮下埋め込み型除細動器価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（心室性頻拍、肥大型心筋症、心室異形成、その他）
- 皮下埋め込み型除細動器の種類別販売量
- 皮下埋め込み型除細動器の種類別売上
- 皮下埋め込み型除細動器の種類別価格
・用途別市場規模（病院、専門診療所、外来手術センター、在宅医療）
- 皮下埋め込み型除細動器の用途別販売量
- 皮下埋め込み型除細動器の用途別売上
- 皮下埋め込み型除細動器の用途別価格
・北米市場
- 北米の皮下埋め込み型除細動器市場規模（種類別、用途別）
- 主要国別の皮下埋め込み型除細動器市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの皮下埋め込み型除細動器市場規模（種類別、用途別）
- 主要国別の皮下埋め込み型除細動器市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の皮下埋め込み型除細動器市場規模（種類別、用途別）
- 主要国別の皮下埋め込み型除細動器市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の皮下埋め込み型除細動器市場規模（種類別、用途別）
- 主要国別の皮下埋め込み型除細動器市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの皮下埋め込み型除細動器市場規模（種類別、用途別）
- 主要国別の皮下埋め込み型除細動器市場規模（トルコ、サウジアラビア）
・企業情報
Abbott、Koninklijke Philips、Nihon Kohden Corporation、Medtronic、Boston Scientific、MicroPort Scientific、ClearPoint Neuro、BIOTRONIK SE、ZOLL Medical
・産業チェーン及び販売チャネル分析
- 皮下埋め込み型除細動器の産業チェーン分析
- 皮下埋め込み型除細動器の原材料
- 皮下埋め込み型除細動器の生産プロセス
- 皮下埋め込み型除細動器の販売及びマーケティング
- 皮下埋め込み型除細動器の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 皮下埋め込み型除細動器の産業動向
- 皮下埋め込み型除細動器のマーケットドライバー
- 皮下埋め込み型除細動器の課題
- 皮下埋め込み型除細動器の阻害要因
・主な調査結果

Unlike the conventionallmplantable Defibrillators which are implanted intravascular, the Subcutaneous lmplantableDefibrillators are inserted subcutaneously under the skin, and uses a subcutaneous electrode placed near the heart, rather than into the heart as in case of conventionallmplantable Defibrillators. A Subcutaneous lmplantable Defibrillator consists of a smalltitanium case which contains battery, a subcutaneous electrode, and accessories such asinsertion tool etc. If there is any abnormality in the patient’s heartbeat, the subcutaneousimplantable defibrillator sends and electrical impulse to restore normalcy in the heartrhythm, followed by pacing therapy in form of post shock bradycardia, if needed.lmplantable defibrillators are useful in saving patients’ lives with known history ofventricular tachycardia and arrhythmias.
Market Analysis and Insights: Global Subcutaneous Implantable Cardioverter Defibrillator Market
Due to the COVID-19 pandemic, the global Subcutaneous Implantable Cardioverter Defibrillator market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Ventricular Tachycardia accounting for % of the Subcutaneous Implantable Cardioverter Defibrillator global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Subcutaneous Implantable Cardioverter Defibrillator market size is valued at US$ million in 2021, while the US and Europe Subcutaneous Implantable Cardioverter Defibrillator are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Subcutaneous Implantable Cardioverter Defibrillator landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Subcutaneous Implantable Cardioverter Defibrillator include Abbott, Koninklijke Philips, Nihon Kohden Corporation, Medtronic, Boston Scientific, MicroPort Scientific, ClearPoint Neuro, BIOTRONIK SE and ZOLL Medical. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Subcutaneous Implantable Cardioverter Defibrillator Scope and Segment
Subcutaneous Implantable Cardioverter Defibrillator market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Subcutaneous Implantable Cardioverter Defibrillator market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Ventricular Tachycardia
Hypertrophic Cardiomyopathy
Ventricular Dysplasia
Others
Segment by Application
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Home Care
By Company
Abbott
Koninklijke Philips
Nihon Kohden Corporation
Medtronic
Boston Scientific
MicroPort Scientific
ClearPoint Neuro
BIOTRONIK SE
ZOLL Medical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Subcutaneous Implantable Cardioverter Defibrillator Product Introduction
1.2 Market by Type
1.2.1 Global Subcutaneous Implantable Cardioverter Defibrillator Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Ventricular Tachycardia
1.2.3 Hypertrophic Cardiomyopathy
1.2.4 Ventricular Dysplasia
1.2.5 Others
1.3 Market by Application
1.3.1 Global Subcutaneous Implantable Cardioverter Defibrillator Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Home Care
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Subcutaneous Implantable Cardioverter Defibrillator Sales Estimates and Forecasts 2017-2028
2.2 Global Subcutaneous Implantable Cardioverter Defibrillator Revenue Estimates and Forecasts 2017-2028
2.3 Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Subcutaneous Implantable Cardioverter Defibrillator Sales by Region
2.4.1 Global Subcutaneous Implantable Cardioverter Defibrillator Sales by Region (2017-2022)
2.4.2 Global Sales Subcutaneous Implantable Cardioverter Defibrillator by Region (2023-2028)
2.5 Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Region
2.5.1 Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Region (2017-2022)
2.5.2 Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Subcutaneous Implantable Cardioverter Defibrillator Sales by Manufacturers
3.1.1 Global Top Subcutaneous Implantable Cardioverter Defibrillator Manufacturers by Sales (2017-2022)
3.1.2 Global Subcutaneous Implantable Cardioverter Defibrillator Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Subcutaneous Implantable Cardioverter Defibrillator in 2021
3.2 Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Manufacturers
3.2.1 Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Manufacturers (2017-2022)
3.2.2 Global Subcutaneous Implantable Cardioverter Defibrillator Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Subcutaneous Implantable Cardioverter Defibrillator Revenue in 2021
3.3 Global Subcutaneous Implantable Cardioverter Defibrillator Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Subcutaneous Implantable Cardioverter Defibrillator Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Subcutaneous Implantable Cardioverter Defibrillator Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Subcutaneous Implantable Cardioverter Defibrillator Sales by Type
4.1.1 Global Subcutaneous Implantable Cardioverter Defibrillator Historical Sales by Type (2017-2022)
4.1.2 Global Subcutaneous Implantable Cardioverter Defibrillator Forecasted Sales by Type (2023-2028)
4.1.3 Global Subcutaneous Implantable Cardioverter Defibrillator Sales Market Share by Type (2017-2028)
4.2 Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Type
4.2.1 Global Subcutaneous Implantable Cardioverter Defibrillator Historical Revenue by Type (2017-2022)
4.2.2 Global Subcutaneous Implantable Cardioverter Defibrillator Forecasted Revenue by Type (2023-2028)
4.2.3 Global Subcutaneous Implantable Cardioverter Defibrillator Revenue Market Share by Type (2017-2028)
4.3 Global Subcutaneous Implantable Cardioverter Defibrillator Price by Type
4.3.1 Global Subcutaneous Implantable Cardioverter Defibrillator Price by Type (2017-2022)
4.3.2 Global Subcutaneous Implantable Cardioverter Defibrillator Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Subcutaneous Implantable Cardioverter Defibrillator Sales by Application
5.1.1 Global Subcutaneous Implantable Cardioverter Defibrillator Historical Sales by Application (2017-2022)
5.1.2 Global Subcutaneous Implantable Cardioverter Defibrillator Forecasted Sales by Application (2023-2028)
5.1.3 Global Subcutaneous Implantable Cardioverter Defibrillator Sales Market Share by Application (2017-2028)
5.2 Global Subcutaneous Implantable Cardioverter Defibrillator Revenue by Application
5.2.1 Global Subcutaneous Implantable Cardioverter Defibrillator Historical Revenue by Application (2017-2022)
5.2.2 Global Subcutaneous Implantable Cardioverter Defibrillator Forecasted Revenue by Application (2023-2028)
5.2.3 Global Subcutaneous Implantable Cardioverter Defibrillator Revenue Market Share by Application (2017-2028)
5.3 Global Subcutaneous Implantable Cardioverter Defibrillator Price by Application
5.3.1 Global Subcutaneous Implantable Cardioverter Defibrillator Price by Application (2017-2022)
5.3.2 Global Subcutaneous Implantable Cardioverter Defibrillator Price Forecast by Application (2023-2028)
6 North America
6.1 North America Subcutaneous Implantable Cardioverter Defibrillator Market Size by Type
6.1.1 North America Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2017-2028)
6.1.2 North America Subcutaneous Implantable Cardioverter Defibrillator Revenue by Type (2017-2028)
6.2 North America Subcutaneous Implantable Cardioverter Defibrillator Market Size by Application
6.2.1 North America Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2017-2028)
6.2.2 North America Subcutaneous Implantable Cardioverter Defibrillator Revenue by Application (2017-2028)
6.3 North America Subcutaneous Implantable Cardioverter Defibrillator Market Size by Country
6.3.1 North America Subcutaneous Implantable Cardioverter Defibrillator Sales by Country (2017-2028)
6.3.2 North America Subcutaneous Implantable Cardioverter Defibrillator Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Subcutaneous Implantable Cardioverter Defibrillator Market Size by Type
7.1.1 Europe Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2017-2028)
7.1.2 Europe Subcutaneous Implantable Cardioverter Defibrillator Revenue by Type (2017-2028)
7.2 Europe Subcutaneous Implantable Cardioverter Defibrillator Market Size by Application
7.2.1 Europe Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2017-2028)
7.2.2 Europe Subcutaneous Implantable Cardioverter Defibrillator Revenue by Application (2017-2028)
7.3 Europe Subcutaneous Implantable Cardioverter Defibrillator Market Size by Country
7.3.1 Europe Subcutaneous Implantable Cardioverter Defibrillator Sales by Country (2017-2028)
7.3.2 Europe Subcutaneous Implantable Cardioverter Defibrillator Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Subcutaneous Implantable Cardioverter Defibrillator Market Size by Type
8.1.1 Asia Pacific Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2017-2028)
8.1.2 Asia Pacific Subcutaneous Implantable Cardioverter Defibrillator Revenue by Type (2017-2028)
8.2 Asia Pacific Subcutaneous Implantable Cardioverter Defibrillator Market Size by Application
8.2.1 Asia Pacific Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2017-2028)
8.2.2 Asia Pacific Subcutaneous Implantable Cardioverter Defibrillator Revenue by Application (2017-2028)
8.3 Asia Pacific Subcutaneous Implantable Cardioverter Defibrillator Market Size by Region
8.3.1 Asia Pacific Subcutaneous Implantable Cardioverter Defibrillator Sales by Region (2017-2028)
8.3.2 Asia Pacific Subcutaneous Implantable Cardioverter Defibrillator Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Subcutaneous Implantable Cardioverter Defibrillator Market Size by Type
9.1.1 Latin America Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2017-2028)
9.1.2 Latin America Subcutaneous Implantable Cardioverter Defibrillator Revenue by Type (2017-2028)
9.2 Latin America Subcutaneous Implantable Cardioverter Defibrillator Market Size by Application
9.2.1 Latin America Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2017-2028)
9.2.2 Latin America Subcutaneous Implantable Cardioverter Defibrillator Revenue by Application (2017-2028)
9.3 Latin America Subcutaneous Implantable Cardioverter Defibrillator Market Size by Country
9.3.1 Latin America Subcutaneous Implantable Cardioverter Defibrillator Sales by Country (2017-2028)
9.3.2 Latin America Subcutaneous Implantable Cardioverter Defibrillator Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Subcutaneous Implantable Cardioverter Defibrillator Market Size by Type
10.1.1 Middle East and Africa Subcutaneous Implantable Cardioverter Defibrillator Sales by Type (2017-2028)
10.1.2 Middle East and Africa Subcutaneous Implantable Cardioverter Defibrillator Revenue by Type (2017-2028)
10.2 Middle East and Africa Subcutaneous Implantable Cardioverter Defibrillator Market Size by Application
10.2.1 Middle East and Africa Subcutaneous Implantable Cardioverter Defibrillator Sales by Application (2017-2028)
10.2.2 Middle East and Africa Subcutaneous Implantable Cardioverter Defibrillator Revenue by Application (2017-2028)
10.3 Middle East and Africa Subcutaneous Implantable Cardioverter Defibrillator Market Size by Country
10.3.1 Middle East and Africa Subcutaneous Implantable Cardioverter Defibrillator Sales by Country (2017-2028)
10.3.2 Middle East and Africa Subcutaneous Implantable Cardioverter Defibrillator Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Overview
11.1.3 Abbott Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Abbott Subcutaneous Implantable Cardioverter Defibrillator Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Recent Developments
11.2 Koninklijke Philips
11.2.1 Koninklijke Philips Corporation Information
11.2.2 Koninklijke Philips Overview
11.2.3 Koninklijke Philips Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Koninklijke Philips Subcutaneous Implantable Cardioverter Defibrillator Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Koninklijke Philips Recent Developments
11.3 Nihon Kohden Corporation
11.3.1 Nihon Kohden Corporation Corporation Information
11.3.2 Nihon Kohden Corporation Overview
11.3.3 Nihon Kohden Corporation Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Nihon Kohden Corporation Subcutaneous Implantable Cardioverter Defibrillator Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Nihon Kohden Corporation Recent Developments
11.4 Medtronic
11.4.1 Medtronic Corporation Information
11.4.2 Medtronic Overview
11.4.3 Medtronic Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Medtronic Subcutaneous Implantable Cardioverter Defibrillator Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Medtronic Recent Developments
11.5 Boston Scientific
11.5.1 Boston Scientific Corporation Information
11.5.2 Boston Scientific Overview
11.5.3 Boston Scientific Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Boston Scientific Subcutaneous Implantable Cardioverter Defibrillator Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Boston Scientific Recent Developments
11.6 MicroPort Scientific
11.6.1 MicroPort Scientific Corporation Information
11.6.2 MicroPort Scientific Overview
11.6.3 MicroPort Scientific Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 MicroPort Scientific Subcutaneous Implantable Cardioverter Defibrillator Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 MicroPort Scientific Recent Developments
11.7 ClearPoint Neuro
11.7.1 ClearPoint Neuro Corporation Information
11.7.2 ClearPoint Neuro Overview
11.7.3 ClearPoint Neuro Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 ClearPoint Neuro Subcutaneous Implantable Cardioverter Defibrillator Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 ClearPoint Neuro Recent Developments
11.8 BIOTRONIK SE
11.8.1 BIOTRONIK SE Corporation Information
11.8.2 BIOTRONIK SE Overview
11.8.3 BIOTRONIK SE Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 BIOTRONIK SE Subcutaneous Implantable Cardioverter Defibrillator Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 BIOTRONIK SE Recent Developments
11.9 ZOLL Medical
11.9.1 ZOLL Medical Corporation Information
11.9.2 ZOLL Medical Overview
11.9.3 ZOLL Medical Subcutaneous Implantable Cardioverter Defibrillator Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 ZOLL Medical Subcutaneous Implantable Cardioverter Defibrillator Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 ZOLL Medical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Subcutaneous Implantable Cardioverter Defibrillator Industry Chain Analysis
12.2 Subcutaneous Implantable Cardioverter Defibrillator Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Subcutaneous Implantable Cardioverter Defibrillator Production Mode & Process
12.4 Subcutaneous Implantable Cardioverter Defibrillator Sales and Marketing
12.4.1 Subcutaneous Implantable Cardioverter Defibrillator Sales Channels
12.4.2 Subcutaneous Implantable Cardioverter Defibrillator Distributors
12.5 Subcutaneous Implantable Cardioverter Defibrillator Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Subcutaneous Implantable Cardioverter Defibrillator Industry Trends
13.2 Subcutaneous Implantable Cardioverter Defibrillator Market Drivers
13.3 Subcutaneous Implantable Cardioverter Defibrillator Market Challenges
13.4 Subcutaneous Implantable Cardioverter Defibrillator Market Restraints
14 Key Findings in The Global Subcutaneous Implantable Cardioverter Defibrillator Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の皮下埋め込み型除細動器市場インサイト及び予測（心室性頻拍、肥大型心筋症、心室異形成、その他）(Global Subcutaneous Implantable Cardioverter Defibrillator Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • C1エステラーゼ阻害剤（皮下）のグローバル市場2023年：500U、1000U
  • 世界の植込み型除細動器（ICD）システム市場インサイト及び予測（シングルチャンバーシステム、デュアルチャンバーシステム）
  • 世界の皮下植込み型除細動器システム市場2022年：シングルゾーン、デュアルゾーン
  • 世界の皮下植込み型除細動器市場2022年：心室性頻脈、肥大型心筋症、心室性異形成症、その他
  • 世界の中古＆再生除細動器市場2022年：自動体外式除細動器、植込み型除細動器、ウェアラブル除細動器、二次救命処置（ALS）